Asset Details
Do you wish to reserve the book?
Exploiting β‐Lactams‐Induced Lysis and DNA Fragmentation for Rapid Molecular Antimicrobial Susceptibility Testing of Neisseria Gonorrhoeae via Dual‐Digital PCR
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Exploiting β‐Lactams‐Induced Lysis and DNA Fragmentation for Rapid Molecular Antimicrobial Susceptibility Testing of Neisseria Gonorrhoeae via Dual‐Digital PCR
Do you wish to request the book?
Exploiting β‐Lactams‐Induced Lysis and DNA Fragmentation for Rapid Molecular Antimicrobial Susceptibility Testing of Neisseria Gonorrhoeae via Dual‐Digital PCR
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Exploiting β‐Lactams‐Induced Lysis and DNA Fragmentation for Rapid Molecular Antimicrobial Susceptibility Testing of Neisseria Gonorrhoeae via Dual‐Digital PCR
2024
Overview
The evolution of antimicrobial resistance (AMR) presents substantial challenges to global medical health systems. Neisseria gonorrhoeae (N. gonorrhoeae), in particular, has developed resistance to all currently available antimicrobials. Addressing this issue necessitates not only discovering new antimicrobials but also deepening the understanding of bacterial responses to these agents, which can lead to new markers for rapid antimicrobial susceptibility testing (AST). Such advancements can enhance treatment outcomes and promote antimicrobial stewardship. In this study, single‐cell techniques, including live‐cell imaging, flow cytometry, and digital polymerase chain reaction (PCR) are utilized, to investigate the lysis dynamics and molecular features of N. gonorrhoeae upon exposure to β‐lactam antimicrobials. Distinct patterns of bacterial lysis and DNA fragmentation are uncovered in susceptible strains. Leveraging these discoveries, a microfluidic dual‐digital PCR approach that combines single‐cell and single‐molecule analyses, facilitate rapid and efficient phenotypic molecular AST for N. gonorrhoeae against β‐lactams is developed. This proof‐of‐concept validation demonstrates the effectiveness of the method in accessing antimicrobial susceptibility across a range of bacterial strains, contributing valuable insights for advancing the battle against AMR. Utilizing DNA fragmentation and abrupt bacterial lysis induced by β‐lactam antimicrobials, a microfluidic dual‐digital PCR that integrates single‐cell and single‐molecule analyses for rapid phenotypic molecular antimicrobial susceptibility testing of Neisseria gonorrhoeae to β‐lactams is developed.
Publisher
John Wiley & Sons, Inc,John Wiley and Sons Inc,Wiley
Subject
Anti-Bacterial Agents - pharmacology
/ Bacteria
/ Cells
/ DNA Fragmentation - drug effects
/ Humans
/ Microbial Sensitivity Tests - methods
/ microfluidic dual‐digital PCR
/ Neisseria gonorrhoeae - drug effects
/ Neisseria gonorrhoeae - genetics
/ Nesseria gonorrhoeae (N. gonorrheoae)
